Basic Information
| LncRNA/CircRNA Name | BLACAT1 |
| Synonyms | BLACAT1, LINC00912, UBC1, onco-lncRNA-30 |
| Region | GRCh38_1:205434886-205437879 |
| Ensemble | ENSG00000281406 |
| Refseq | NR_103783 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | PTC tissues |
| Expression Pattern | down-regulated |
| Function Description | BLACAT1 could act as a possible suppressor gene in PTC and may serve as a potential biomarker for prognosis prediction of PTC. BLACAT1 expression was associated with LNM andgender |
| Pubmed ID | 29599647 |
| Year | 2018 |
| Title | Prognostic value of long non-coding RNA BLACAT1 in patients with papillary thyroid carcinoma. |
External Links
| Links for BLACAT1 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |